Chronic
Migraine
Treatment of Chronic Migraine with the
natural approach of NeuroResearch
Clinics is very straight forward and
highly effective. 100% of patients that
experience a Migraine achieve
relief of symptoms.
This
does not mean that 100% of patients
claiming to suffer from a Chronic
Migraine periodically at the initial
clinic visit will achieve relief of
symptoms. Research data indicates that
85% of people presenting at the clinic
will achieve relief of Migraine
symptoms. The other 15% represent people
claiming recurrent Migraine
symptoms but in fact have a chronic headaches
caused by other things. These people may
have been mis-diagnosed with the
Chronic Migraine
diagnosis in the past or inappropriately
adopted the Chronic Migraine
diagnosis on their own. The 15%
of patients who think they have a
Migraine problem and don't will
benefit as well, since now there is the
ability to focus on what the real cause
of the headache is and make a proper
diagnosis.
Migraine drugs such as Imitrex
and Zomig are expensive (about $200 for
nine pills). Many doctors believe that
taking these drugs insure another
Migraine will develop. Treatment results
better than drugs without the drugs.
Case study Using The
NeuroResearch Clinics Chronic Migraine Approach
Chronic Migraine Case study
By: David Healow, MD
Billings, Montana
A 45-year-old woman presented with intractable
classic Chronic Migraine since she was a teen. She worked
as a medical receptionist, so had unusual access to
multiple formal and informal consultations and
treatments but continued to have a Migraine
almost every day. She lost approximately 3 days per month
to bed rest due to her pain. She was otherwise
healthy, except for a history of surviving
osteogenic sarcoma treated by hemipelvectomy, with
recurrence treated by further femoral resection.
Despite resulting skeletal defect and a 6 inch leg
length discrepancy, she regularly walks several
miles each morning for exercise.
After seeing several people respond to the
5-HTP, tyrosine, levodopa, and cysteine therapy
of NeuroResearch Clinics, she asked to try.
She has not had another Migraine since the
start of treatment, she continues
on a half dose of level 1 NeuroResearch Clinics
treatment protocol. She reports
only occasional mild visual aura but no headache
recurrence,
no Chronic Migraine days or bed rest for the year since
starting.
DISCUSSION:
A true
Chronic Migraine will respond well to properly balanced
5-HTP, tyrosine, levodopa, and cysteine treatment.
If the person has been titrated up to the level 3
dosing and there is no Migraine relief, it
is a good time to question if diagnosing the source
of the problem as Migraine was correct.
When treating a Migraine the results
discussed above are common.
Its no secret, NeuroResearch Clinics uses the nutrients 5-HTP, tyrosine, levodopa,
and cysteine to treat medical
patients in order to get these
results. Proper
use of these simple ingredients in
medical treatment is not simple.
From time to time a patient will
say, "Why do I want to take that, I
can go to a health food store and
buy it?" People off the street
buying in a health food store is
like going to an art store and
buying a bunch of oil paints then
going home and expecting to paint
like a mater artist even though
there was no previous painting
experience. These nutrients have
tremendous potential due to their
chemical properties. This potential
is only fully realized in the hands
of the trained professional using
neurotransmitter testing. Treatment
is not just giving a nutrient pill, it is the whole medical management approach doctors are trained in to insure that that treatment is on track in order to get symptoms under control.
The Peer Reviewed Research
of NeuroResearch Clinics
The neurotransmitter treatment research findings of NeuroResearch Clinics
have not been ignored. The University of
Minnesota Medical School is writing a series of
papers on the neurotransmitter testing research of NeuroResearch Clinics. The first of a series of papers by University of Minnesota Medical School based on the neurotransmitter testing research of NeuroResearch was published in "NeuroPsychiatric Disease and Treatment" May 1, 2009. Ingrid
Kohlstadt, MD of Johns Hopkins in her new
medical text book released February 7, 2009
included a chapter on depression written by
Marty L. Hinz, MD President Clinical
Research NeuroResearch Clinics outlining in
depth the proper use of amino acids and
neurotransmitter testing in treatment of
depression.
Chronic
Migraine
research |
